论文部分内容阅读
联苯双酯是目前公认的有效降酶药,对慢性肝病所致ALT升高者,有效率可达90％,复常率可达80％左右,且具有降酶速度快、幅度大的优点,临床运用较为普遍。但我们在长期的临床运用中发现,联苯双酯在降低ALT的同时,往往致AST升高,导致AST/ALT的比值失常。为此,我们在临床中尝试加用易善力或氨基酸制剂,以使AST复常,AST/ALT比值恢复,现将观察结果报告如下。
Bifendate is currently recognized as an effective antihypertensive drug, chronic liver disease caused by elevated ALT, the effective rate of up to 90%, normalization rate of up to 80%, and has the advantage of reducing enzyme speed, range Clinical application is more common. However, we found in the long-term clinical application, bifendate in lowering ALT at the same time, often lead to elevated AST, resulting in abnormal AST / ALT ratio. To this end, we try to add in the clinical use of good or good power or amino acid preparations, in order to AST normal, AST / ALT ratio recovery, the observations are reported below.